Preview

Cardiovascular Therapy and Prevention

Advanced search

Stability of serum biochemical markers during standard long-term storage and with a single thawing

https://doi.org/10.15829/1728-8800-2020-2736

Abstract

Aim. To study the effect of standard serum long-term storage at -70О C and with a single thawing on the biochemical markers by comparing the results of studies carried out in 2013-2014 and 2020.

Material and methods. The material was the blood serum of participants in the ESSE-RF study, which was stored in a specialized biobank from 2013-2014 at -70О C either continuously (n=149) or with a single thawing (n=20). Initially and in 2020, the quantitative determination of serum biochemical parameters was carried out using same equipment and standard techniques.

Results. Long-term storage at -70О C led to mild, but significant changes in almost all analyzed parameters: low density lipoprotein cholesterol (LDL-C) and apolipoprotein A1 levels decreased; levels of highdensity lipoprotein cholesterol (HDL-C), triglycerides, apolipoprotein B, glucose, and high-sensitivity C-reactive protein increased. Insulin and thyroid-stimulating hormone levels did not change during storage. The revealed strong positive relationships between the initial concentrations and those measured in 2020 in samples that were stored continuously indicate the relevance of such storage. In samples with single thawing, changes in most parameters were more pronounced.

Conclusion. The results of a prospective cohort study aimed at studying the stability of human serum samples during storage indicate the validity of long-term storage at -70О C without thawing. Freeze-thawing cycle of samples (even once) is unacceptable, since it leads to a pronounced LDL-C decrease. Given the fact that it is the LDL-C levels that is the target of lipid-lowering therapy, continuous low-temperature (not >-70О C) storage of blood serum samples is recommended.

About the Authors

V. A. Kozlova
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
Moscow


V. A. Metelskaya
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
Moscow


M. S. Pokrovskaya
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
Moscow


I. A. Efimova
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
Moscow


O. A. Litinskaya
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
Moscow


V. A. Kutsenko
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
Moscow


E. B. Yarovaya
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
Moscow


S. A. Shalnova
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
Moscow


O. M. Drapkina
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
Moscow


References

1. Ellervik C, Vaught J. Preanalytical variables affecting the integrity of human biospecimens in biobanking. Clin Chem. 2015;61(7):914-34. doi:10.1373/clinchem.2014.228783.

2. Kang HJ, Jeon SY, Park J-S, et al. Identification of Clinical Biomarkers for Pre-Analytical Quality Control of Blood Samples. Biopreserv Biobank. 2013;11(2):94-100. doi:10.1089/bio.2012.0051.

3. A guide to qualify your clinical samples. https://www.findmyassay.com/ (15.08.2020).

4. Sivakova OV, Pokrovskaya MS, Efimova IA, et al. Quality control of serum and plasma samples for scientific research. The Russian Journal of Preventive Medicine. 2019;22(5):91-7. (In Russ.) doi:10.17116/profmed20192205191.

5. Chen WC, Kerr R, May A, et al. The Integrity and Yield of Genomic DNA Isolated from Whole Blood Following Long-Term Storage at -30ОC. Biopreserv Biobank. 2018;16(2):106-13. doi:10.1089/bio.2017.0050.

6. Kisand K, Kerna I, Kumm J. Impact of Cryopreservation on Serum Concentration of Matrix Metalloproteinases (MMP)-7, TIMP-1, Vascular Growth Factors (VEGF) and VEGF-R2 in Biobank Samples. Clin Chem Lab Med. 2011;49(2):229-35. doi:10.1515/CCLM.2011.049.

7. Lee J-E, Kim SY, Shin S-Y. Effect of Repeated Freezing and Thawing on Biomarker Stability in Plasma and Serum Samples. Osong Public Health Res Perspect. 2015;6(6):357-62. doi:10.1016/j.phrp.2015.11.005.

8. Bünger S, Klempt-Giessing K, Toner V, et al. A Novel MultiplexProtein Array for Serum Diagnostics of Colorectal Cancer: Impact of Pre-Analytical Storage Conditions. Biopreserv Biobank. 2013;11(6):379-86. doi:10.1089/bio.2013.0050.

9. Boytsov SA, Chazov EI, Shlyakhto EV, et al. Epidemiology of cardiovascular diseases in different regions of Russia (ESSERF). The rationale for and design of the study. Preventive Medicine. 2013;16(6):25-34. (In Russ.)

10. Moore HM, Kelly A, Jewell SD, et al. Biospecimen reporting for improved study quality. Biopreserv Biobank. 2011;9(1):57-70. doi:10.1089/bio.2010.0036.

11. Sivakova OV, Pokrovskaya MS, Metelskaya VA, et al. International rules for description of biospecimens are an important factor in improving the quality of researches. The Russian Journal of Preventive Medicine. 2019;22(6):91-7. (In Russ.) doi:10.17116/profmed20192206295.

12. Evans K, Mitcheson J, Laker MF. Effect of Storage at -70ОC on Lipid, Lipoprotein and Apolipoprotein Concentrations. Clin Chim Acta. 1997;258(2):219-29. doi:10.1016/s0009-8981(96)06458-3.

13. Kuchmak M, Taylor L, Olansky AS. Suitability of Frozen and Lyophilized Reference Sera for Cholesterol and Triglyceride Determinations. Clin Chim Acta. 1982;120(2):261-71. doi:10.1016/0009-8981(82)90163-2.

14. Yu R, Dan Y, Xiang X. Stability of Chronic Hepatitis-Related Parameters in Serum Samples After Long-Term Storage. Biopreserv Biobank. 2017;15(3):211-9. doi:10.1089/bio.2016.0043.

15. Cuhadar S, Koseoglu M, Atay A, Dirican A. The Effect of Storage Time and Freeze-Thaw Cycles on the Stability of Serum Samples. Biochem Med. 2013;23(1):70-7. doi:10.11613/bm.2013.009.

16. Clark S, Youngman LD, Palmer A, et al. Stability of Plasma Analytes after Delayed Separation of Whole Blood: Implications for Epidemiological Studies. Int J Epidemiol. 2003;32(1):125-30. doi:10.1093/ije/dyg023.

17. Waateringe RP, Muller AC, Kobold AC, et al. Influence of Storage and Interand Intra-Assay Variability on the Measurement of Inflammatory Biomarkers in Population-Based Biobanking. Biopreserv Biobank. 2017:15(6):512-8. doi:10.1089/bio.2017.0001.

18. Nordestgaard BG, Langsted A, Mora S, et al. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points. A joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J. 2016;37(25):1944-58. doi:10.1093/eurheartj/ehw152.

19. Ricos C, Alvarez V, Cava F, et al. Current Databases on Biologic Variation: Pros, Cons and Progress. Scand J Clin Lab Invest. 1999;59(7):491-500. doi:10.1080/00365519950185229.

20. Westgard QC. Desirable specifications for total error, imprecision, and bias, derived from intra-and inter-individual biological variation. Available at: http://www.westgard.com/ biodatabase1.htm.

21. Lermen D, Gwinner F, Bartel-Steinbach M, et al. Towards Harmonized Biobanking for Biomonitoring: A Comparison of Human Biomonitoring-Related and Clinical Biorepositories. Biopreserv Biobank. 2020;18(2):122-35. doi:10.1089/2019.0092.


Supplementary files

Review

For citations:


Kozlova V.A., Metelskaya V.A., Pokrovskaya M.S., Efimova I.A., Litinskaya O.A., Kutsenko V.A., Yarovaya E.B., Shalnova S.A., Drapkina O.M. Stability of serum biochemical markers during standard long-term storage and with a single thawing. Cardiovascular Therapy and Prevention. 2020;19(6):2736. (In Russ.) https://doi.org/10.15829/1728-8800-2020-2736

Views: 1197


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1728-8800 (Print)
ISSN 2619-0125 (Online)